Lilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will supply its active pharmaceutical ingredient (API) for human insulin at a reduced price to International...
Source: prnewswire.com